WELLS FARGO & COMPANY/MN - SIGILON THERAPEUTICS INC ownership

SIGILON THERAPEUTICS INC's ticker is SGTX and the CUSIP is 82657L107. A total of 34 filers reported holding SIGILON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SIGILON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$96
+166.7%
103
+1.0%
0.00%
Q4 2022$36102
+3.0%
0.00%
Q3 2022$099
+1.0%
0.00%
Q2 2022$0
-100.0%
98
-98.9%
0.00%
Q1 2022$13,000
-66.7%
8,975
-37.2%
0.00%
Q4 2021$39,000
-92.1%
14,301
-83.6%
0.00%
Q3 2021$494,000
+180.7%
87,383
+432.3%
0.00%
Q2 2021$176,000
+225.9%
16,417
+581.5%
0.00%
Q1 2021$54,0002,4090.00%
Other shareholders
SIGILON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 740,740$35,578,00013.90%
Flagship Pioneering Inc. 10,370,369$498,089,0009.07%
Monashee Investment Management LLC 561,628$26,975,0003.56%
SPHERA FUNDS MANAGEMENT LTD. 567,460$26,061,0002.31%
Avidity Partners Management LP 688,000$33,045,0001.07%
SECTORAL ASSET MANAGEMENT INC 225,000$10,807,0000.76%
Artal Group S.A. 276,000$13,256,0000.28%
GILDER GAGNON HOWE & CO LLC 662,227$31,807,0000.16%
CANADA PENSION PLAN INVESTMENT BOARD 1,485,185$71,333,0000.11%
Perceptive Advisors 125,000$6,004,0000.06%
View complete list of SIGILON THERAPEUTICS INC shareholders